These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 28342726)

  • 1. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Detection of Fetal Aneuploidy Using Next Generation Sequencing.
    Curnow KJ; Sanderson RK; Beruti S
    Methods Mol Biol; 2019; 1885():325-345. PubMed ID: 30506208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
    Shaffer BL; Norton ME
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing.
    Kim SY; Lee SM; Jun JK; Han YJ; Kim MH; Shim JY; Lee MY; Oh SY; Lee J; Kim SH; Cha DH; Cho GJ; Kwon HS; Kim BJ; Park MH; Cho HY; Ko HS; Ahn J; Ryu HM
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):307. PubMed ID: 30041617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Forward Look At Noninvasive Prenatal Testing.
    Liu L; Li K; Fu X; Chung C; Zhang K
    Trends Mol Med; 2016 Nov; 22(11):958-968. PubMed ID: 27726956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma.
    Dharajiya N; Zwiefelhofer T; Guan X; Angkachatchai V; Saldivar JS
    Curr Protoc Hum Genet; 2015 Jan; 84():8.15.1-8.15.20. PubMed ID: 25599670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
    Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations.
    Nshimyumukiza L; Menon S; Hina H; Rousseau F; Reinharz D
    Clin Genet; 2018 Jul; 94(1):3-21. PubMed ID: 29030960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
    Stoll K; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
    Gray KJ; Wilkins-Haug LE
    Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result.
    Long AA; Abuhamad AZ; Warsof SL
    Clin Lab Med; 2016 Jun; 36(2):249-59. PubMed ID: 27235910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening.
    Luo Y; Jia B; Yan K; Liu S; Song X; Chen M; Jin F; Du Y; Wang J; Hong Y; Cao S; Li D; Dong M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00597. PubMed ID: 30767419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
    Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
    JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.